Context

• India’s 2026–27 Union Budget, along with its new Free Trade Agreement (FTA) with the European Union, represents a pivotal moment for Ayurveda and other traditional systems of medicine.
• These developments signal a transition from viewing Ayurveda as an alternative practice to integrating it into both the national healthcare system and the global medical marketplace.
• While this expansion reflects ambition and opportunity, it also raises important questions about scientific credibility, regulatory standards, and the balance between tradition and evidence.

Strengthening Ayurveda within India

• Increased Budgetary Support
  • The Indian government’s growing commitment to Ayurveda is evident in the significant rise in funding for the AYUSH Ministry, which has nearly doubled over the past five years.
  • This financial expansion reflects a policy shift aimed at embedding traditional medicine within the mainstream healthcare system rather than treating it as a parallel alternative.
• Institutional Development and Research
  • The announcement of three new All-India Institutes of Ayurveda marks an important step toward institutionalising traditional medicine.
  • These institutes are expected to function as centres of excellence, combining patient care with advanced research and education, much like premier institutions in modern medicine.
  • Additionally, the expansion of the National AYUSH Mission aims to modernise dispensaries, integrate AYUSH clinics into government hospitals, and strengthen drug-testing infrastructure.
  • Together, these measures are designed to enhance both accessibility and quality.

Global Expansion through the India–EU FTA

• Opportunities in International Markets
  • The India–EU FTA provides Ayurveda with unprecedented global exposure.
  • It allows Indian practitioners to offer services in certain European countries and enables Indian companies to establish Ayurvedic clinics abroad.
  • The agreement also opens the possibility of mutual recognition of safety certifications, potentially simplifying the export of Ayurvedic products.
• Regulatory Challenges and Expectations
  • However, entering global markets also means operating within stringent regulatory frameworks. Ayurveda, as part of Traditional, Complementary, and Alternative Medicine (TCAM), will be evaluated based on international standards of safety, efficacy, and quality.
  • This transition requires regulatory harmonisation and adherence to scientific norms that govern global healthcare systems.

The Imperative of Scientific Evidence

• Bridging the Gap Between Claims and Proof
  • A major challenge in Ayurveda’s global journey is the gap between traditional claims and scientific validation.
  • Without robust evidence, there is a risk of legal disputes, reputational harm, and the reinforcement of stereotypes about unscientific practices.
• Need for Independent Research
  • Currently, much of the research on AYUSH systems is conducted or overseen by the same institutions that promote them, raising concerns about conflicts of interest.
  • To build global credibility, Ayurveda must undergo rigorous, independent scientific evaluation. This includes:
    • Independently funded clinical trials
    • Transparent research methodologies
    • Peer-reviewed publications
    • Willingness to publish negative findings
  • Such measures are essential for establishing trust in international markets.

Rethinking the Debate: Science and Tradition

• Beyond the Colonial Argument
  • Criticism of scientific scrutiny is sometimes framed as resistance to Western epistemological dominance.
  • While colonial history did marginalise indigenous medical systems, equating all demands for evidence with cultural bias is misleading.
  • Scientific evaluation should not be seen as a threat but as a necessary step toward validation and acceptance.
• Science as Strength, Not Threat
  • Demanding empirical evidence does not diminish tradition; rather, it strengthens it.
  • By engaging with scientific methods, Ayurveda can demonstrate its efficacy and relevance in a global context, thereby enhancing its legitimacy.

Coexistence of Medical Systems

• Distinct Conceptual Frameworks
  • Ayurveda and modern biomedicine are based on fundamentally different understandings of the body and health.
  • Ayurveda views the body as an interconnected system influenced by environmental, dietary, and social factors, with health defined as a state of equilibrium.
  • In contrast, biomedicine focuses on anatomical localisation and targeted interventions.
• Complementarity Rather Than Competition
  • The relationship between these systems should not be seen as oppositional. Instead, they can function as complementary approaches:
  • Biomedicine offers precision and targeted treatment
  • Ayurveda provides a holistic and integrative perspective
  • Together, they can broaden the understanding of health and enhance the scope of care.

Conclusion

• Ayurveda’s expansion, supported by domestic policy and international agreements, represents a transformative moment in India’s healthcare landscape.
• The future of Ayurveda depends not on assertion or cultural pride alone, but on its willingness to embrace rigorous evaluation, transparency, and intellectual openness.
• By focusing on dialogue between tradition and science, India has the opportunity to position Ayurveda as a credible and valuable contributor to global healthcare.
• Ultimately, its success will be determined by evidence, integrity, and the courage to be critically examined.